Legal Rep Support for Clinical Investigations and Performance Studies
Elpisia Europe provides practical regulatory coordination and legal representation support relating to selected clinical investigations for medical devices under MDR and performance studies for IVD products under IVDR, subject to applicable regulatory requirements and project scope.
We work with sponsors and manufacturers to support regulatory communication, documentation coordination, and applicable compliance processes associated with European clinical investigation activities.
• Support for applicable legal representation arrangements
• Regulatory communication coordination
• Documentation management support
• Serious adverse event reporting coordination assistance where applicable
The Role of a Legal Representative
Under applicable European regulations, certain sponsors conducting clinical investigations for medical devices or performance studies for IVD products within the European Union may require a Legal Representative established in the EU, depending on the sponsor’s location and the applicable regulatory framework.
The Legal Representative may serve as a regulatory contact point for competent authorities in relation to applicable clinical investigation or performance study activities. Similar requirements may also apply in other jurisdictions such as the United Kingdom and Switzerland under their respective regulatory frameworks.
The Legal Representative does not act as the sponsor, investigator, or CRO, and does not conduct the study or make scientific, medical, or operational decisions on behalf of the sponsor.
Elpisia Europe may provide practical legal representation and regulatory coordination support relating to selected clinical investigations and performance studies within the agreed project scope and applicable regulations.
Key Support Areas
• Regulatory communication and authority coordination support
• Documentation availability and coordination assistance
• Assistance relating to serious adverse event communication processes where applicable
• Regulatory correspondence coordination
• EU-based contact and representation support where applicable
Sponsor Responsibilities
Sponsors generally remain responsible for the clinical investigation or performance study, including compliance with applicable regulatory requirements, study conduct, safety oversight, documentation, investigator/site management, insurance obligations, and applicable reporting activities.
Manufacturers and sponsors are generally expected to maintain appropriate communication with their Legal Representative regarding relevant regulatory or study-related matters.
The Work Flow
We review the proposed study scope, applicable jurisdictions, target timelines, and regulatory requirements to assess the appropriate legal representation and regulatory support arrangement.
Following project confirmation, the applicable legal representation arrangement and onboarding process are established in accordance with the relevant regulatory framework and agreed project scope.
Where applicable, Elpisia Europe may support regulatory submission coordination and documentation relating to legal representation requirements within the relevant jurisdictions.
During the study period, we may assist with regulatory communication coordination, documentation availability support, and applicable authority correspondence within the agreed scope of service.
At study completion, Elpisia Europe may assist with applicable regulatory closure coordination and documentation retention support in accordance with the relevant regulatory requirements and agreed project scope.
Frequently asked Questions
A Legal Representative is an EU-based entity designated by certain non-EU sponsors in relation to clinical investigations or IVD performance studies conducted under applicable European regulatory frameworks.
The Legal Representative may support regulatory communication and coordination activities relating to the applicable study and jurisdiction.
Applicable European regulations may require certain non-EU sponsors conducting clinical investigations or IVD performance studies in Europe to appoint an EU-based Legal Representative.
The Legal Representative may support regulatory communication, documentation coordination, and authority-related processes associated with the applicable study and jurisdiction.
Applicable European regulations may require certain sponsors located outside the European Union to appoint an EU-based Legal Representative for clinical investigations or IVD performance studies conducted within the EU.
The Legal Representative may support regulatory communication and coordination activities relating to the applicable study and jurisdiction.
No. The Legal Representative role for clinical investigations or IVD performance studies is separate from the EU Authorized Representative role associated with products placed on the European market under MDR or IVDR.
The two functions serve different regulatory purposes and may be handled separately depending on the applicable project and regulatory requirements.
No. Study design, protocol development, and scientific or operational decisions generally remain the responsibility of the sponsor and appointed study partners.
Elpisia Europe focuses on applicable legal representation and regulatory coordination support within the agreed project scope.
Elpisia Europe may assist with coordination relating to applicable serious adverse event communication and regulatory reporting processes within the agreed project scope.
Medical assessment, documentation, and safety-related decision-making generally remain the responsibility of the sponsor.
Elpisia Europe may assist with applicable legal representation and regulatory coordination activities for clinical investigations or IVD performance studies conducted across EU member states, subject to the relevant regulatory requirements and project scope.
Additional jurisdiction-specific requirements may apply for countries outside the European Union.
Depending on the project scope and applicable regulations, sponsors may be requested to provide relevant regulatory and study-related documentation necessary for legal representation and regulatory coordination activities.
This may include study protocols, regulatory submissions, ethics-related documentation, and applicable authority correspondence where relevant.
Applicable regulations may require certain regulatory and study-related documentation to be retained for extended periods depending on the product type, study scope, and jurisdiction involved.
Retention periods generally depend on the relevant regulatory framework and applicable legal requirements.